维生素D干预治疗对肥胖及相关代谢异常的影响

被引：16

作者：

尹晓 ^{[1
]}

阎玲 ^{[2
]}

陆勇 ^{[1
]}

机构：

[1] 山东大学附属济南市中心医院内分泌科

[2] 山东大学附属济南市中心医院干部保健科

来源：

山东大学学报(医学版) | 2011年 / 49卷 / 03期

关键词：

肥胖症; 维生素D; 代谢综合症;

D O I：

暂无

中图分类号：

R589.2 [脂肪代谢障碍];

学科分类号：

100201 [内科学];

摘要：

目的选择我国北方地区的中年肥胖人群,研究超重肥胖人群维生素D缺乏与肥胖相关代谢异常的关系及维生素D干预治疗的影响。方法在健康查体人员中入选肥胖者201例,按照是否合并代谢综合症分为单纯性肥胖组和肥胖并代谢综合症组,比较两组血清25-OH-VitD水平及各代谢指标与血清25-OH-VitD的相关关系。肥胖并代谢综合症组中有88例合并维生素D缺乏,随机分为干预治疗组和对照组,两组均接受12周的生活方式干预减轻体质量,干预治疗组同时口服维生素D和钙剂,观察干预前后代谢指标的变化。结果单纯性肥胖组和肥胖并代谢综合症组血清25-OH-VitD水平无明显差异(P>0.05),体质量指数(body mass index,BMI)、血甘油三酯与血清25-OH-VitD水平显著相关(P<0.05)。肥胖患者体质量减轻过程中,补充维生素D和钙剂对改善血甘油三酯水平有独立的贡献(P<0.05)。结论我国超重肥胖人群维生素D水平与BMI和血甘油三酯相关,且在减轻体质量过程中,维生素D干预可以进一步改善肥胖症患者的血脂异常。

引用

页码：1 / 4+12 +12

页数：5

共 10 条

[1]

Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study [J].

Cheng, Susan ;

Massaro, Joseph M. ;

Fox, Caroline S. ;

Larson, Martin G. ;

Keyes, Michelle J. ;

McCabe, Elizabeth L. ;

Robins, Sander J. ;

O'Donnell, Christopher J. ;

Hoffmann, Udo ;

Jacques, Paul F. ;

Booth, Sarah L. ;

Vasan, Ramachandran S. ;

Wolf, Myles ;

Wang, Thomas J. .

DIABETES, 2010, 59 (01) :242-248

[2]

Threshold for Effects of Vitamin D Deficiency on Glucose Metabolism in Obese Female African-American Adolescents [J].

Ashraf, Ambika ;

Alvarez, Jessica ;

Saenz, Karen ;

Gower, Barbara ;

McCormick, Kenneth ;

Franklin, Frank .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3200-3206

[3]

Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals [J].

Lu, Ling ;

Yu, Zhijie ;

Pan, An ;

Hu, Frank B. ;

Franco, Oscar H. ;

Li, Huaixing ;

Li, Xiaoying ;

Yang, Xilin ;

Chen, Yan ;

Lin, Xu .

DIABETES CARE, 2009, 32 (07) :1278-1283

[4]

Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index [J].

Konradsen, Steinar ;

Ag, Harald ;

Lindberg, Fedon ;

Hexeberg, Sofie ;

Jorde, Rolf .

EUROPEAN JOURNAL OF NUTRITION, 2008, 47 (02) :87-91

[5]

25-Hydroxyvitamin D; IGF-1; and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort.[J].Hypp?nen; Elina;Boucher; Barbara J;Berry; Diane J;Power; Chris.Diabetes.2008, 2

[6]

Vitamin D, PTH, and the metabolic syndrome in severely obese subjects [J].

Rueda, Sergio ;

Fernandez-Fernandez, Cristian ;

Romero, Fabiola ;

de Osaba, Ma. Jesus Martinez ;

Vidal, Josep .

OBESITY SURGERY, 2008, 18 (02) :151-154

[7]

The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis.[J].Anastassios G. Pittas;Joseph Lau;Frank B. Hu;Bess Dawson-Hughes.The Journal of Clinical Endocrinology & Metabolism.2007, 6

[8]

Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].

Grundy, SM ;

Cleeman, JI ;

Daniels, SR ;

Donato, KA ;

Eckel, RH ;

Franklin, BA ;

Gordon, DJ ;

Krauss, RM ;

Savage, PJ ;

Smith, SC ;

Spertus, JA ;

Costa, F .

CIRCULATION, 2005, 112 (17) :2735-2752

[9]

The metabolic syndrome [J].

Eckel, RH ;

Grundy, SM ;

Zimmet, PZ .

LANCET, 2005, 365 (9468) :1415-1428

[10]

PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium; vitamin D; and alcohol on body weight.[J].M.F McCarty;C.A Thomas.Medical Hypotheses.2003, 5

← 1 →